Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Beth A Overmoyer

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Cancer|October 10, 2022
Incidence, characteristics, and management of central nervous system metastases in patients with inflammatory breast cancerLaura E G Warren, Samuel M Niman, Marie C Remolano, et al.
Seminars in Oncology|February 19, 2005
The role of the liposomal anthracyclines and other systemic therapies in the management of advanced breast cancerNicholas J Robert, Charles L Vogel, I Craig Henderson, et al.
Breast Cancer Research and Treatment|October 12, 2013
Prospective clinical experience with research biopsies in breast cancer patientsInes Vaz-Luis, Catherine A Zeghibe, Elizabeth S Frank, et al.
European Journal of Cancer (Oxford, England : 1990)|September 18, 2022
HER2-low inflammatory breast cancer: Clinicopathologic features and prognostic implicationsPaolo Tarantino, Samuel M Niman, Timothy K Erick, et al.
Cancer Chemotherapy and Pharmacology|April 17, 2008
Phase I clinical and pharmacokinetic study of oxaliplatin, irinotecan and capecitabineSmitha S Krishnamurthi, Joanna M Brell, Charles L Hoppel, et al.
The Oncologist|October 30, 2016
Phase II and Biomarker Study of Cabozantinib in Metastatic Triple-Negative Breast Cancer PatientsSara M Tolaney, David R Ziehr, Hao Guo, et al.
The New England Journal of Medicine|January 8, 2015
Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancerSara M Tolaney, William T Barry, Chau T Dang, et al.
Breast Cancer Research and Treatment|April 21, 2019
Local-regional recurrence in women with small node-negative, HER2-positive breast cancer: results from a prospective multi-institutional study (the APT trial)Jennifer R Bellon, Hao Guo, William T Barry, et al.
Breast Cancer Research and Treatment|May 19, 2015
Chemotherapy-related amenorrhea after adjuvant paclitaxel-trastuzumab (APT trial)Kathryn J Ruddy, Hao Guo, William Barry, et al.
Journal of the National Cancer Institute|March 31, 2025
Development of a Multi-Institutional Dataset to Validate a Novel Inflammatory Breast Cancer Diagnostic ScoreFilipa Lynce, Samuel M Niman, Megumi Kai, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Cancer|October 10, 2022
Incidence, characteristics, and management of central nervous system metastases in patients with inflammatory breast cancerLaura E G Warren, Samuel M Niman, Marie C Remolano, et al.
Seminars in Oncology|February 19, 2005
The role of the liposomal anthracyclines and other systemic therapies in the management of advanced breast cancerNicholas J Robert, Charles L Vogel, I Craig Henderson, et al.
Breast Cancer Research and Treatment|October 12, 2013
Prospective clinical experience with research biopsies in breast cancer patientsInes Vaz-Luis, Catherine A Zeghibe, Elizabeth S Frank, et al.
European Journal of Cancer (Oxford, England : 1990)|September 18, 2022
HER2-low inflammatory breast cancer: Clinicopathologic features and prognostic implicationsPaolo Tarantino, Samuel M Niman, Timothy K Erick, et al.
Cancer Chemotherapy and Pharmacology|April 17, 2008
Phase I clinical and pharmacokinetic study of oxaliplatin, irinotecan and capecitabineSmitha S Krishnamurthi, Joanna M Brell, Charles L Hoppel, et al.
The Oncologist|October 30, 2016
Phase II and Biomarker Study of Cabozantinib in Metastatic Triple-Negative Breast Cancer PatientsSara M Tolaney, David R Ziehr, Hao Guo, et al.
The New England Journal of Medicine|January 8, 2015
Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancerSara M Tolaney, William T Barry, Chau T Dang, et al.
Breast Cancer Research and Treatment|April 21, 2019
Local-regional recurrence in women with small node-negative, HER2-positive breast cancer: results from a prospective multi-institutional study (the APT trial)Jennifer R Bellon, Hao Guo, William T Barry, et al.
Breast Cancer Research and Treatment|May 19, 2015
Chemotherapy-related amenorrhea after adjuvant paclitaxel-trastuzumab (APT trial)Kathryn J Ruddy, Hao Guo, William Barry, et al.
Journal of the National Cancer Institute|March 31, 2025
Development of a Multi-Institutional Dataset to Validate a Novel Inflammatory Breast Cancer Diagnostic ScoreFilipa Lynce, Samuel M Niman, Megumi Kai, et al.
Pageof 3